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Background: The promotion of patient safety and drug safety through promotion of pharmacist’s drug safety
practice was among the most important aims of China’s health delivery system reform, but regional inequity in
pharmacist’s drug safety practice was still serious in China.
Methods: The 2011 national patient safety and medication error baseline survey was carried out for the first time in
China, and through analyzing dataset from the survey, this study was set up to test both China’s regional inequity
in pharmacist’s drug safety practice and major influencing factors for pharmacist’s drug safety practice among
different districts of China.
Results: Pharmacist’s drug safety practice in regions with higher per capita GDP and more abundant medical
resources was still better than that in regions with lower per capita GDP and less abundant medical resources. In all
districts of China, pharmacist’s drug safety knowledge, drug safety attitude, self-perceived pressure and fatigue,
hospital management quality, and hospital regulation were major influencing factors for pharmacist’s drug safety
practice, while only in regions with higher per capita GDP and more abundant medical resources, hospital drug
safety culture, supervisor’s work team management, cooperation atmosphere of work team, and drug safety culture
of work team were major influencing factors for pharmacist’s drug safety practice.
Conclusion: Regional inequity in pharmacist’s drug safety practice still existed in China. In all districts of China,
promoting pharmacist’s drug safety knowledge, drug safety attitude, self-perceived pressure and fatigue, hospital
management quality, and hospital regulation could help promote pharmacist’s drug safety practice, while only in
regions with higher per capita GDP and more abundant medical resources, promoting hospital drug safety culture,
supervisor’s work team management, cooperation atmosphere of work team, and drug safety culture of work team
could help promote pharmacist’s drug safety practice. And in regions with lower per capita GDP and less abundant
medical resources, the link between pharmacist’s drug safety practice and hospital drug safety culture/supervisor’s
work team management/cooperation atmosphere of work team/drug safety culture of work team should also be
gradually established.Background
The promotion of patient safety and drug safety through
promotion of pharmacist’s drug safety practice was one
of the most important aims of China’s health delivery
system reform [1]. At the national level, Ministry of
Health, State Administration of Traditional Chinese
Medicine, and State Food and Drug Administration
issued many policies on strengthening drug safety man-
agement in pharmacy, improving drug safety related
pharmacy service quality, and establishing/improvingCorrespondence: tly09@mails.tsinghua.edu.cn
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reproduction in any medium, provided the orcontrol system for the management of drug safety
related pharmacy service quality, in the project of Hos-
pital Management Year pharmacist’s drug safety practice
was also especially emphasized [2-8]. Although these
policies and measures promoted pharmacist’s drug safety
consciousness and improved drug safety related phar-
macy service quality to a certain degree all around
China, due to serious regional inequity in economic
resources and medical resources, the attention paid to
the promotion of patient safety and drug safety through
promotion of pharmacist’s drug safety practice varied
across regions [9]. In fact China’s regional inequity in
both economic resources and medical resources wasis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gistic reasons: regional market failure and insufficient re-
gional government stewardship, regional inequitable
distribution of social determinants of economic
resources/medical resources, and regional public dissat-
isfaction with the fairness and trustworthiness of eco-
nomic/medical resource allocation system [10]. In
this context, due to different degrees of regional market
failure and different levels of regional government man-
agement capacity, different degrees of secondary distri-
bution adjustment for regional inequitable distribution
of social determinants of economic resources/medical
resources, and different degrees of regional public confi-
dence in the fairness and trustworthiness of economic/
medical resource allocation system among different dis-
tricts of China, the efforts in promoting patient safety
and drug safety through promoting pharmacist’s drug
safety practice were significantly different among regions
[10-15], and regions with higher per capita GDP and
more abundant medical resources usually performed
better on the promotion of patient safety and drug safety
through promotion of pharmacist’s drug safety practice
than regions with lower per capita GDP and less abun-
dant medical resources [9]. As researchers have already
pointed out, regional inequity in pharmacist’s drug safety
practice was still serious in China [16-22].
Many previous studies separately found that pharma-
cist’s drug safety knowledge, drug safety attitude, and
drug safety environment (involving facility and equip-
ment, regulation, personal pressure and fatigue, hospital
management quality, hospital drug safety culture, and
drug safety culture of work team) were major influen-
cing factors for pharmacist’s drug safety practice both at
the national level and at the regional level [23-39], but
the regional differences in major influencing factors for
pharmacist’s drug safety practice haven’t been studied
under a systematic and comprehensive framework, and
then the relative importance of influencing factors for
pharmacist’s drug safety practice among different dis-
tricts of China wasn’t clear [9].
Some previous studies further subdivided pharmacist’s
drug safety practice into detailed aspects, most of
them only focused on pharmacist’s basic drug safety
practice (including drug management, pharmacist’s dis-
pensing behavior, and medication error recording and
reporting) and its major influencing factors, while little
study focused on pharmacist’s advanced drug safety
practice (including medication error analysis, sharing
and correction, and implementation of drug safety sys-
tem and measure) and its major influencing factors
[9,23-27,29,30,32,33,35-39]. And there was no previous
study which explored regional differences in major in-
fluencing factors for detailed aspects of pharmacist’s
drug safety practice in China [9].Besides shortcomings and deficiencies mentioned
above, there were several other serious problems with
these previous studies: most of these studies obtained
their conclusions only through qualitative analysis and
authors’ experiences, while little study adopted strict
quantitative analysis, and their conclusions were usually
drawn on the basis of a small range of pharmacists, then
the robustness and universality of their conclusions
remained controversial [23,24,26-32,34-39].
Aim of the study
Under the background of China’s health delivery sys-
tem reform, in order to find the most effective ways to
promote patient safety and drug safety through pro-
moting pharmacist’s drug safety practice among differ-
ent districts of China, this study first carried out the
2011 national patient safety and medication error base-
line survey, and then through analyzing dataset from
the survey, this study tested both China’s regional in-
equity in pharmacist’s drug safety practice and major
influencing factors for pharmacist’s drug safety practice
among different districts of China. On the basis of
main findings, inspirations on regional differences in
effective ways to promote patient safety and drug safety
through promoting pharmacist’s drug safety practice




The 2011 national patient safety and medication error
baseline survey was carried out by the patient safety and
drug safety research group (this research group con-
sisted of the pharmacy department of Peking University
Third Hospital, the science and technology development
center of Chinese Pharmaceutical Association, and Tsin-
ghua University). Through the stratified sampling
method, 126 hospitals from 26 provinces, autonomous
regions, and municipalities directly under the central
government were chosen, and among them 112 hospi-
tals responded to this survey (the response rate was
88.89%). 5844 pharmacists in these 112 hospitals were
chosen through the stratified sampling design, and
among them 1959 pharmacists completed the question-
naire with assistance from the patient safety and drug
safety research group (the rate of valid questionnaire
was 33.52%).
Questionnaire for the patient safety and medication
error baseline survey was designed on the basis of ques-
tionnaire for hospital survey on patient safety culture
[40], patient safety/drug safety situation in China, and
pharmacy experts’ experiences, it contained four parts:
the first part inquired about pharmacist’s drug safety
knowledge (including 24 questions), the second part
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ing 16 questions), the third part inquired about pharma-
cist’s drug safety environment (including 28 questions),
and the fourth part inquired about pharmacist’s drug
safety practice (including 34 questions). Pharmacist’s
drug safety environment and drug safety practice were
further subdivided into detailed aspects: drug safety en-
vironment was composed of the aspect of physical work
environment, the aspect of self-perceived pressure and
fatigue, the aspect of hospital management quality, the
aspect of hospital regulation, the aspect of hospital drug
safety culture, the aspect of supervisor’s work team man-
agement, the aspect of cooperation atmosphere of work
team, and the aspect of drug safety culture of work team;
drug safety practice was composed of the aspect of drug
management, the aspect of pharmacist’s prescription dis-
pensing behavior, the aspect of standardization of physi-
cian’s prescription (special aspect since it needed the
cooperation of doctor and pharmacist), the aspect of
medication error recording and reporting, the aspect
of medication error analysis, sharing and correction,
and the aspect of implementation of drug safety sys-
tem and measure. At the beginning of questionnaire,
there were detailed explanations for professional nouns
in the following questions, and at the end of question-
naire, pharmacists were asked for their personal attri-
bute information involving personal average working
load (daily processing of prescription/doctor’s advice),
personal professional title, and personal professional
position. 112 hospitals which responded to this survey
were asked for hospital attribute information involving
hospital level, length of hospital history, and hospital
type. All these selected personal attributes and hospital
attributes were considered as possible influencing factors
for pharmacist’s drug safety practice by the research
group, they were split into dummy variables and were
mainly treated as control variables in regression analysis,
and their detailed explanations could be found in
Table 1.
The use of the dataset was approved by the science
and technology development center of Chinese Pharma-
ceutical Association.
Regional grouping according to regional economic
resources/medical resources
In this study, according to the regional per capita GDP
and the ranking of richness of regional medical resources
(calculated based on per capita medical service resources
and per capita medical personnel resources in level 3
hospitals/level 2 hospitals) in 2010 (data in 2010 was
chosen because the 2011 national patient safety and
medication error baseline survey mainly collected infor-
mation in 2010) [9], 26 provinces, autonomous regions,
and municipalities directly under the central governmentwere divided into 3 groups through clustering analysis
(presented in Figure 1):
1. Regions with the highest per capita GDP and the
most abundant medical resources (Group 1): Beijing,
Shanghai;
2. Regions with the second highest per capita GDP and
the second most abundant medical resources (Group
2): Guangdong, Tianjin, Zhejiang, Jiangsu, Shandong,
Liaoning, Fujian;
3. Regions with the lowest per capita GDP and the least
abundant medical resources (Group 3): Hebei,
Henan, Shanxi, Jiangxi, Hubei, Hunan, Anhui,
Heilongjiang, Jilin, Sichuan, Guizhou, Gansu,
Yunnan, Hainan, Xinjiang, Shaanxi, Ningxia.
Measures of pharmacist’s drug safety knowledge, drug
safety attitude, drug safety environment, and drug
safety practice
The 5-item self-reporting measure that assessed each
question in the questionnaire on a scale of 1 to 5 was
employed, higher score reflected better performance in
the question: the option “excellent performance” was
assigned score 5, the option “good performance” was
assigned score 4, and the option “general performance”
was assigned score 3, the option “bad performance” was
assigned score 2, and the option “poor performance”
was assigned score 1.
Pharmacist’s drug safety knowledge, drug safety atti-
tude, drug safety environment/detailed aspects of drug
safety environment, and drug safety practice/detailed
aspects of drug safety practice were all composed of sev-
eral questions in the questionnaire, and the weighted
average score of corresponding question set was the
overall score for pharmacist’s drug safety knowledge/
drug safety attitude/drug safety environment or its
detailed aspect/drug safety practice or its detailed aspect.
Regression model
In order to test major influencing factors for pharma-
cist’s drug safety practice among different districts of
China, the following ordinary least squares (OLS) regres-
sion model was separately estimated for different re-
gional groups:








βp4zpi þ Ei 1ð Þ
here i was sample number; practicei was drug safety
practice; knowledgei was drug safety knowledge; attitudei
was drug safety attitude; environmentni (n = 1,2,. . .,8)
were detailed aspects of drug safety environment; zpi
Table 1 Descriptive statistics of personal attributes and hospital attributes
Dummy variables Descriptions Mean Standard deviation
Personal average working
load dummy variables
1 = The number of prescriptions/doctor’s advices processed
per day is 0, 0 =Otherwise
0.163 0.370
1 = The number of prescriptions/doctor’s advices processed
per day is between 1 and 100, 0 =Otherwise
0.247 0.432
1 = The number of prescriptions/doctor’s advices processed
per day is between 101 and 300, 0 =Otherwise
0.249 0.432
1 = The number of prescriptions/doctor’s advices processed
per day is between 301 and 500, 0 =Otherwise
0.161 0.367
1 = The number of prescriptions/doctor’s advices processed




1 = Practice pharmacist, 0 =Otherwise 0.035 0.185
1 =Assistant pharmacist (junior title), 0 =Otherwise 0.112 0.315
1 = Pharmacist (junior title), 0 =Otherwise 0.360 0.480
1 = Competent pharmacist (intermediate title), 0 =Otherwise 0.325 0.469
1 =Associate senior pharmacist (senior title), 0 =Otherwise 0.125 0.331
1 = Senior pharmacist (senior title), 0 =Otherwise 0.042 0.202
Personal professional position
dummy variables
1 =Drug dispensing position in outpatient pharmacy/
emergency pharmacy, 0 =Otherwise
0.456 0.498
1 =Drug dispensing position in inpatient pharmacy, 0 =Otherwise 0.178 0.382
1 = Position in drug storehouse, 0 =Otherwise 0.082 0.275
1 =Hospital preparation production position, 0 =Otherwise 0.042 0.201
1 = Position in intravenous compounding center, 0 =Otherwise 0.058 0.235
1 = Clinical pharmacy position, 0 =Otherwise 0.133 0.340
1 =Other position for part-time job, 0 =Otherwise 0.006 0.075
1 =Other position, 0 =Otherwise 0.044 0.206
Hospital level dummy variables 1 = Sample pharmacist is in Second-Class Hospital at Grade 2, 0 =Otherwise 0.003 0.055
1 = Sample pharmacist is in First-Class Hospital at Grade 2, 0 =Otherwise 0.097 0.297
1 = Sample pharmacist is in Second-Class Hospital at Grade 3, 0 =Otherwise 0.092 0.289
1 = Sample pharmacist is in First-Class Hospital at Grade 3, 0 =Otherwise 0.808 0.394
Length of hospital history
dummy variables
1 = Sample pharmacist is in hospital established before the founding of the
People’s Republic of China, 0 =Otherwise
0.429 0.495
1 = Sample pharmacist is in hospital established after the founding of the
People’s Republic of China, 0 =Otherwise
0.493 0.500
Hospital type dummy variables 1 = Sample pharmacist is in traditional Chinese medicine specialized
hospital, 0 =Otherwise
0.002 0.045
1 = Sample pharmacist is in western medicine specialized
hospital, 0 =Otherwise
0.078 0.268
1 = Sample pharmacist is in traditional Chinese medicine general
hospital, 0 =Otherwise
0.033 0.179
1 = Sample pharmacist is in integrated traditional and western medicine
general hospital, 0 =Otherwise
0.022 0.146
1 = Sample pharmacist is in western medicine general hospital, 0 =Otherwise 0.865 0.341
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(involving personal average working load, personal pro-
fessional title, and personal professional position) and
hospital attributes (involving hospital level, length of
hospital history, and hospital type) may be key influen-
cing factors for pharmacist’s drug safety practice, theywere all controlled as dummy variables in the regression
model; error term Ei was assumed to be distributed
normal.
In order to test major influencing factors for detailed
aspects of pharmacist’s drug safety practice among dif-
ferent districts of China, the following six OLS
Figure 1 Regional grouping result.
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separately estimated for different regional groups:








βp4zpi þ Ei 2ð Þ  7ð Þ
here practiceqi (q = 1,2,. . .,6) were detailed aspects of
drug safety practice; descriptions of other variables were
the same as those in regression model (1).
Results
Descriptive statistics
The descriptive statistics of pharmacist’s drug safety
knowledge, drug safety attitude, detailed aspects of drug
safety environment, drug safety practice, and detailed
aspects of drug safety practice were presented in Table 2.
From the descriptive statistics of drug safety practice/
detailed aspects of drug safety practice, regional inequity
in pharmacist’s drug safety practice still existed in China,
and specifically speaking, regional inequity in all detailed
aspects of pharmacist’s drug safety practice still existed
in China. From the descriptive statistics of major influ-
encing factors for pharmacist’s drug safety practice, re-
gional inequity in pharmacist’s drug safety knowledge,drug safety attitude, and detailed aspects of drug safety
environment still existed in China.
Regression results on pharmacist’s drug safety practice
Results of regression model (1) were presented in
Table 3. From the significance and size of the coefficient
for drug safety knowledge/drug safety attitude/detailed
aspect of drug safety environment, major influencing
factors for pharmacist’s drug safety practice among dif-
ferent districts of China were revealed as follows.
In group 1, the most important influencing factors for
pharmacist’s drug safety practice were hospital regula-
tion and drug safety culture of work team, and the sec-
ond most important influencing factors for pharmacist’s
drug safety practice were pharmacist’s drug safety atti-
tude, cooperation atmosphere of work team, and phar-
macist’s drug safety knowledge, while hospital drug
safety culture, supervisor’s work team management, self-
perceived pressure and fatigue, and hospital manage-
ment quality also had significant positive influences on
pharmacist’s drug safety practice, but physical work en-
vironment had no influence on pharmacist’s drug safety
practice.
In group 2, the most important influencing factor for
pharmacist’s drug safety practice was hospital regulation,
and the second most important influencing factors for
Table 2 Descriptive statistics of pharmacist’s drug safety knowledge, drug safety attitude, drug safety environment,
and drug safety practice
Group 1 (N= 777) Group 2 (N= 511) Group 3 (N= 671)
Variable Mean Mean Mean Standard deviation Min Max
Drug safety knowledge 3.462 3.454 3.444 0.226 1 5
Drug safety attitude 3.758 3.722 3.690 0.452 1 5
Physical work environment 3.327 3.291 3.110 0.810 1 5
Self-perceived pressure and fatigue 3.373 3.242 3.221 0.851 1 5
Hospital management quality 2.809 2.716 2.603 1.144 1 5
Hospital regulation 4.014 3.965 3.951 0.462 1 5
Hospital drug safety culture 3.395 3.378 3.325 0.370 1 5
Supervisor’s work team management 3.771 3.747 3.697 0.601 1 5
Cooperation atmosphere of work team 3.693 3.674 3.619 0.501 1 5
Drug safety culture of work team 3.154 3.153 3.140 0.372 1 5
Drug safety practice 3.753 3.659 3.658 0.482 1 5
Drug management 4.110 4.084 4.059 0.467 1 5
Pharmacist’s prescription
dispensing behavior
3.949 3.817 3.761 0.519 1 5
Standardization of physician’s prescription 3.545 3.495 3.314 0.632 1 5
Medication error recording and reporting 3.681 3.595 3.557 1.045 1 5
Medication error analysis, sharing
and correction
3.666 3.573 3.537 0.824 1 5
Implementation of drug safety system
and measure
3.659 3.603 3.581 0.544 1 5
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ture of work team and pharmacist’s drug safety know-
ledge, while pharmacist’s drug safety attitude, hospital
drug safety culture, self-perceived pressure and fatigue,
and hospital management quality also had significant
positive influences on pharmacist’s drug safety practice,
but physical work environment, supervisor’s work team
management, and cooperation atmosphere of work team
had no influence on pharmacist’s drug safety practice.
In group 3, the most important influencing factor for
pharmacist’s drug safety practice was hospital regulation,
and the second most important influencing factor for
pharmacist’s drug safety practice was pharmacist’s drug
safety knowledge, while pharmacist’s drug safety attitude,
self-perceived pressure and fatigue, and hospital man-
agement quality also had significant positive influences
on pharmacist’s drug safety practice, but physical work
environment, hospital drug safety culture, supervisor’s
work team management, cooperation atmosphere of
work team, and drug safety culture of work team had no
influence on pharmacist’s drug safety practice.
Regression results on detailed aspects of pharmacist’s
drug safety practice
Results of regression model (2)-(7) were correspondingly
presented in Table 4 ,Table 5, and Table 6. From thesignificance and size of the coefficient for drug safety
knowledge/drug safety attitude/detailed aspect of drug
safety environment, major influencing factors for
detailed aspects of pharmacist’s drug safety practice
among different districts of China were revealed as
follows.
For the aspect of drug management, hospital regula-
tion and pharmacist’s drug safety knowledge were major
influencing factors in all three groups, drug safety cul-
ture of work team was major influencing factor only in
group 1, and hospital management quality had small
positive influence on drug management in all three
groups.
For the aspect of pharmacist’s prescription dispensing
behavior, pharmacist’s drug safety knowledge, hospital
regulation, and pharmacist’s drug safety attitude were
major influencing factors in all three groups, self-
perceived pressure and fatigue and hospital management
quality also had significant positive influences on phar-
macist’s prescription dispensing behavior in all three
groups, while drug safety culture of work team, cooper-
ation atmosphere of work team, hospital drug safety cul-
ture, and supervisor’s work team management were
major influencing factors only in group 1.
For the aspect of standardization of physician’s pre-
scription (special aspect since it needed the cooperation
Table 3 Results of regression model (1)
(1) (2) (3)
Drug safety practice
Group 1 Group 2 Group 3
Drug safety knowledge 0.228*** 0.223*** 0.218***
(3.62) (3.01) (3.10)
Drug safety attitude 0.263*** 0.126*** 0.118**
(7.19) (2.93) (2.40)
Physical work environment 0.00614 0.0204 0.0367
(0.32) (0.70) (1.52)
Self-perceived pressure and fatigue 0.0788*** 0.102*** 0.110***
(2.76) (2.61) (2.96)
Hospital management quality 0.0408* 0.0480* 0.0538*
(1.91) (1.79) (1.81)
Hospital regulation 0.318*** 0.393*** 0.432***
(9.25) (8.34) (10.53)
Hospital drug safety culture 0.134** 0.111** 0.0775
(2.40) (2.06) (1.13)























Hospital type dummy variables Yes Yes Yes
Constant −0.641 −0.399 −0.896**
(−1.47) (−1.02) (−2.48)
N 1959 1959 1959
R2 0.614 0.688 0.638
t statistics in parentheses, * p< 0.10,** p< 0.05,*** p< 0.01.
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was major influencing factor in group 1, self-perceived
pressure and fatigue was major influencing factor in
group 3, and both of them were major influencing fac-
tors in group 2.
For the aspect of medication error recording and
reporting, hospital regulation was major influencing fac-
tor in all three groups, drug safety culture of work team
and hospital drug safety culture were major influencing
factors only in group 1 and group 2, while cooperationatmosphere of work team and supervisor’s work team
management were major influencing factors only in
group 1.
For the aspect of medication error analysis, sharing
and correction, hospital regulation, pharmacist’s drug
safety attitude, and physical work environment were
major influencing factors in all three groups, drug safety
culture of work team was major influencing factor only
in group 1 and group 2, while cooperation atmosphere
of work team, hospital drug safety culture, and supervi-
sor’s work team management were major influencing
factors only in group 1.
For the aspect of implementation of drug safety system
and measure, self-perceived pressure and fatigue, phar-
macist’s drug safety attitude, and hospital regulation
were major influencing factors in all three groups, and
hospital management quality also had significant positive
influence on implementation of drug safety system and
measure in all three groups, drug safety culture of work
team and hospital drug safety culture were major influ-
encing factors only in group 1 and group 2, while co-
operation atmosphere of work team and supervisor’s
work team management were major influencing factors
only in group 1.
Discussion
Main findings of this study
Regional inequity in pharmacist’s drug safety practice
still existed in China, and pharmacist’s drug safety prac-
tice in regions with higher per capita GDP and more
abundant medical resources was still better than that in
regions with lower per capita GDP and less abundant
medical resources. Generally speaking, major influencing
factors for pharmacist’s drug safety practice could be
divided into two categories: the first category consisted
of pharmacist’s drug safety knowledge, drug safety atti-
tude, self-perceived pressure and fatigue, hospital man-
agement quality, and hospital regulation, they were
usually major influencing factors for pharmacist’s drug
safety practice/detailed aspects of pharmacist’s drug
safety practice in all districts of China; the second cat-
egory consisted of hospital drug safety culture, supervi-
sor’s work team management, cooperation atmosphere
of work team, and drug safety culture of work team, they
were usually major influencing factors for pharmacist’s
drug safety practice/detailed aspects of pharmacist’s drug
safety practice only in regions with higher per capita
GDP and more abundant medical resources.
The main cause of the above findings was that major
influencing factors for pharmacist’s drug safety practice
in the first category were paid attention to all around
China, which induced that the link between pharmacist’s
drug safety practice and influencing factors in the first
category had already been established in all regions of
Table 4 Results of regression model (2)-(3)
(1) (2) (3) (4) (5) (6)
Drug management Pharmacist’s prescription dispensing behavior
Group 1 Group 2 Group 3 Group 1 Group 2 Group 3
Drug safety knowledge 0.340*** 0.268*** 0.219*** 0.405*** 0.364*** 0.294***
(5.09) (3.40) (2.79) (3.84) (3.76) (3.27)
Drug safety attitude 0.0590 0.0527 0.0178 0.241*** 0.213*** 0.151**
(0.63) (1.09) (0.39) (4.63) (3.83) (2.33)
Physical work environment 0.00729 0.0338 0.0238 −0.0265 −0.0170 −0.0172
(0.36) (1.18) (0.93) (−0.97) (−0.44) (−0.55)
Self-perceived pressure and fatigue 0.0173 0.0456 0.0543 0.0697* 0.0739** 0.112***
(0.45) (0.88) (0.78) (1.77) (2.44) (2.76)
Hospital management quality 0.0302* 0.0509** 0.0701*** 0.0371** 0.0710** 0.132**
(1.94) (2.25) (2.78) (2.12) (2.30) (2.48)
Hospital regulation 0.563*** 0.579*** 0.638*** 0.236*** 0.268*** 0.400***
(15.48) (12.53) (14.66) (3.79) (5.47) (7.49)
Hospital drug safety culture 0.0454 0.0425 0.0196 0.141*** −0.0737 0.0867
(0.80) (0.63) (0.33) (2.64) (−0.81) (1.20)
Supervisor’s work team management 0.0465 0.0472 0.0149 0.125* −0.0249 −0.00480
(1.40) (1.20) (0.38) (1.67) (−0.56) (−0.10)
Cooperation atmosphere of work team 0.0289 0.0393 0.0196 0.202*** 0.0369 0.0372
(0.84) (0.91) (0.47) (2.64) (0.64) (0.72)
Drug safety culture of work team 0.130* −0.00236 −0.0513 0.294*** 0.151*** 0.103
(1.90) (−0.04) (−0.84) (3.75) (2.97) (1.38)
Personal average working load dummy variables Yes Yes Yes Yes Yes Yes
Personal professional title dummy variables Yes Yes Yes Yes Yes Yes
Personal professional position dummy variables Yes Yes Yes Yes Yes Yes
Hospital level dummy variables Yes Yes Yes Yes Yes Yes
Length of hospital history dummy variables Yes Yes Yes Yes Yes Yes
Hospital type dummy variables Yes Yes Yes Yes Yes Yes
Constant 0.00810 0.355 0.379 1.294** 0.622 −0.415
(0.02) (0.93) (1.03) (2.08) (1.20) (−0.92)
N 777 511 671 777 511 671
R2 0.554 0.653 0.585 0.343 0.477 0.462
t statistics in parentheses, * p< 0.10,** p< 0.05,*** p< 0.01.
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safety practice in the second category were paid special
attention to only in regions with higher per capita GDP
and more abundant medical resources, which induced
that the link between pharmacist’s drug safety practice
and influencing factors in the second category had been
established only in regions with higher per capita GDP
and more abundant medical resources, and such link
didn’t exist in regions with lower per capita GDP and
less abundant medical resources [9].
Among major influencing factors for pharmacist’s drug
safety practice in the first category: hospital regulation,
pharmacist’s drug safety knowledge, and pharmacist’sdrug safety attitude were always the most important in-
fluencing factors for pharmacist’s drug safety practice in
all regions of China; hospital regulation was major influ-
encing factor for all detailed aspects of pharmacist’s drug
safety practice all around China; and pharmacist’s drug
safety knowledge was major influencing factor for both
the aspect of drug management and the aspect of phar-
macist’s prescription dispensing behavior in all regions
of China; pharmacist’s drug safety attitude was major in-
fluencing factor for the aspect of pharmacist’s prescrip-
tion dispensing behavior, the aspect of medication error
analysis, sharing and correction, and the aspect of imple-
mentation of drug safety system and measure all around
Table 5 Results of regression model (4)-(5)
(1) (2) (3) (4) (5) (6)
Standardization of physician’s prescription Medication error recording and reporting
Group 1 Group 2 Group 3 Group 1 Group 2 Group 3
Drug safety knowledge 0.192 0.0639 0.0465 0.218 0.217 0.128
(1.37) (0.42) (0.40) (0.82) (0.93) (0.71)
Drug safety attitude 0.111* 0.0701 0.0726 0.248* 0.107 0.0862
(1.66) (0.74) (0.90) (1.84) (0.66) (0.79)
Physical work environment −0.0196 0.0677 −0.0200 −0.0412 −0.0714 0.00982
(−0.56) (1.21) (−0.44) (−0.72) (−0.74) (0.13)
Self-perceived pressure and fatigue 0.0821* 0.166*** 0.344*** −0.0880 0.113 0.0572
(1.71) (3.15) (4.59) (−1.02) (0.88) (0.49)
Hospital management quality −0.0475 −0.0170 −0.0255 0.0183 −0.117 0.0746
(−1.21) (−0.48) (−0.57) (0.29) (−1.33) (1.00)
Hospital regulation 0.116* 0.144* 0.171* 0.476*** 0.538*** 0.728***
(1.82) (1.87) (1.90) (4.61) (4.18) (4.69)
Hospital drug safety culture 0.371*** 0.230** −0.0000900 0.447** 0.259*** 0.205
(2.83) (2.20) (−0.00) (2.47) (2.66) (1.17)
Supervisor’s work team management 0.0876 0.00741 0.0131 0.289** 0.157* 0.0154
(1.51) (0.10) (0.19) (2.18) (1.66) (0.13)
Cooperation atmosphere of work team −0.0700 0.0642 0.0971 0.362*** 0.257 −0.0461
(−1.52) (1.07) (1.16) (2.91) (1.13) (−0.32)
Drug safety culture of work team −0.0225 0.119 0.0744 0.607*** 0.490** 0.0645
(−0.26) (1.05) (0.69) (4.21) (2.51) (0.40)
Personal average working load
dummy variables
Yes Yes Yes Yes Yes Yes
Personal professional title
dummy variables
Yes Yes Yes Yes Yes Yes
Personal professional position
dummy variables
Yes Yes Yes Yes Yes Yes
Hospital level dummy variables Yes Yes Yes Yes Yes Yes
Length of hospital history
dummy variables
Yes Yes Yes Yes Yes Yes
Hospital type dummy variables Yes Yes Yes Yes Yes Yes
Constant 0.906 1.453* 0.589 −3.043** −1.928 −1.289
(1.12) (1.94) (0.90) (−2.32) (−1.49) (−1.18)
N 777 511 671 777 511 671
R2 0.236 0.308 0.258 0.293 0.251 0.229
t statistics in parentheses, * p< 0.10,** p< 0.05,*** p< 0.01.
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major influencing factor for both the aspect of
standardization of physician’s prescription and the as-
pect of implementation of drug safety system and meas-
ure in all regions of China; while hospital management
quality had significant positive influence on the aspect
of drug management, the aspect of pharmacist’s pre-
scription dispensing behavior, and the aspect of imple-
mentation of drug safety system and measure all
around China.Among major influencing factors for pharmacist’s drug
safety practice in the second category: only in regions
with higher per capita GDP and more abundant medical
resources, both drug safety culture of work team and co-
operation atmosphere of work team were the most im-
portant influencing factors for pharmacist’s drug safety
practice, and both hospital drug safety culture and
supervisor’s work team management were the second
most important influencing factors for pharmacist’s drug
safety practice; hospital drug safety culture, supervisor’s
Table 6 Results of regression model (6)-(7)
(1) (2) (3) (4) (5) (6)
Medication error analysis, sharing and correction Implementation of drug safety system and measure
Group 1 Group 2 Group 3 Group 1 Group 2 Group 3
Drug safety knowledge 0.267* 0.183 0.0165 0.129* 0.0961 0.00376
(1.66) (1.32) (0.09) (1.87) (1.12) (0.04)
Drug safety attitude 0.358*** 0.350*** 0.368*** 0.233*** 0.167*** 0.107**
(4.44) (3.19) (3.03) (5.84) (3.14) (2.16)
Physical work environment 0.102** 0.149** 0.159*** −0.0178 −0.0202 0.00407
(2.42) (2.31) (3.02) (−0.85) (−0.64) (0.15)
Self-perceived pressure
and fatigue
−0.0410 −0.0548 0.0233 0.239*** 0.242*** 0.254***
(−0.65) (−0.63) (0.29) (7.64) (5.71) (5.93)
Hospital management
quality
−0.0434 −0.0243 0.0110 0.0508* 0.0711*** 0.0814***
(−0.92) (−0.41) (0.42) (1.76) (2.97) (3.04)
Hospital regulation 0.433*** 0.455*** 0.534*** 0.102*** 0.207*** 0.280***
(5.72) (4.35) (5.97) (2.70) (4.06) (5.91)
Hospital drug safety culture 0.290** 0.0894 0.0371 0.254*** 0.191*** −0.0423
(2.21) (1.25) (0.54) (5.85) (4.46) (−0.66)
Supervisor’s work team
management
0.273** −0.0281 −0.0919 0.174*** −0.0959 −0.0986
(2.17) (−0.31) (−1.14) (5.07) (−1.63) (−1.33)
Cooperation atmosphere
of work team
0.395*** 0.105 0.0979 0.387*** 0.0618 0.0549
(3.33) (1.08) (1.13) (5.81) (1.31) (1.20)
Drug safety culture
of work team
0.406*** 0.122*** 0.171 0.416*** 0.376*** 0.0593*
(2.67) (3.15) (1.62) (7.95) (5.88) (1.67)
Personal average working
load dummy variables
Yes Yes Yes Yes Yes Yes
Personal professional title
dummy variables
Yes Yes Yes Yes Yes Yes
Personal professional
position dummy variables
Yes Yes Yes Yes Yes Yes
Hospital level dummy
variables
Yes Yes Yes Yes Yes Yes
Length of hospital
history dummy variables
Yes Yes Yes Yes Yes Yes
Hospital type dummy
variables
Yes Yes Yes Yes Yes Yes
Constant −1.928** −0.971 −1.857** 0.101 −0.309 −0.987**
(−2.00) (−1.12) (−2.45) (0.21) (−0.73) (−2.46)
N 777 511 671 777 511 671
R2 0.390 0.433 0.396 0.596 0.751 0.638
t statistics in parentheses, * p< 0.10,** p< 0.05,*** p< 0.01.
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team, and drug safety culture of work team were major
influencing factors for the aspect of pharmacist’s pre-
scription dispensing behavior, the aspect of medicationerror recording and reporting, the aspect of medication
error analysis, sharing and correction, and the aspect
of implementation of drug safety system and measure
only in regions with higher per capita GDP and more
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safety culture was major influencing factor for the aspect
of standardization of physician’s prescription in regions
with higher per capita GDP and more abundant medical
resources.
What is already known on this topic
Previous studies separately showed that pharmacist’s
drug safety knowledge, drug safety attitude, and some
detailed aspects of drug safety environment (involving
facility and equipment, regulation, personal pressure and
fatigue, hospital management quality, hospital drug
safety culture, and drug safety culture of work team) all
had positive influences on pharmacist’s drug safety prac-
tice [23-39], but their influences on pharmacist’s drug
safety practice haven’t been studied under the same
framework, and then their relative importance in influ-
encing pharmacist’s drug safety practice wasn’t clear,
most importantly, regional differences of their relative
importance in influencing pharmacist’s drug safety prac-
tice haven’t been studied before [9].
For detailed aspects of pharmacist’s drug safety prac-
tice, most previous studies only focused on pharmacist’s
basic drug safety practice (involving drug management,
pharmacist’s prescription dispensing behavior, and medi-
cation error recording and reporting) and its major in-
fluencing factors, while little study paid attention to
pharmacist’s advanced drug safety practice (involving
medication error analysis, sharing and correction, and
implementation of drug safety system and measure) and
its major influencing factors [9,23-27,29,30,32,33,35-39].
And there was no previous study which explored re-
gional differences in major influencing factors for
detailed aspects of pharmacist’s drug safety practice in
China.
Most previous studies mentioned above obtained their
conclusions only through qualitative analysis and
authors’ experiences, while little study adopted strict
quantitative analysis, and their conclusions were usually
drawn on the basis of a small range of pharmacists, then
the robustness and universality of their conclusions
remained controversial [23,24,26-32,34-39], and their
conclusions couldn’t be directly used for regional com-
parative study.
What this study adds
The most important contribution of this study was that
both China’s regional inequity in pharmacist’s drug safety
practice and major influencing factors for pharmacist’s
drug safety practice among different districts of China
were studied under a systematic and comprehensive
framework for the first time. The second most important
contribution of this study was that in order to perform
the strict quantitative analysis, this study carried out thelarge-scale national patient safety and medication error
baseline survey for the first time in China. The third
most important contribution was that major influencing
factors for pharmacist’s drug safety practice/detailed
aspects of pharmacist’s drug safety practice among dif-
ferent districts of China were found for the first time in
China, and compared with previous studies, the robust-
ness and universality of these findings were much better.
On the basis of major findings, in China’s future health
delivery system reform, the following inspirations on re-
gional differences in effective ways to promote patient
safety and drug safety through promoting pharmacist’s
drug safety practice were found: major influencing fac-
tors for pharmacist’s drug safety practice in the first cat-
egory (involving pharmacist’s drug safety knowledge,
drug safety attitude, self-perceived pressure and fatigue,
hospital management quality, and hospital regulation)
should be further promoted in order to promote phar-
macist’s drug safety practice in all districts of China;
major influencing factors for pharmacist’s drug safety
practice in the second category (involving hospital drug
safety culture, supervisor’s work team management, co-
operation atmosphere of work team, and drug safety cul-
ture of work team) should be further promoted in order
to promote pharmacist’s drug safety practice in regions
with higher per capita GDP and more abundant medical
resources; the link between pharmacist’s drug safety
practice and major influencing factors in the second
category should be gradually established in regions
with lower per capita GDP and less abundant medical
resources.
Limitation of this study
Several limitations should be noted. First, the response
rate of the national patient safety and medication error
baseline survey was only 33.52%, and then the collected
sample slightly deviated from the stratified sampling de-
sign, which may have slight influence on the above find-
ings. In fact the deviation of the collected sample was
that the percentage of pharmacists in level 3 hospitals
was slightly higher than the percentage in stratified sam-
pling design, while the percentage of pharmacists in level
2 hospitals was slightly lower than the percentage in
stratified sampling design. Second, due to the fact that
questionnaire for the survey was designed on the basis
of questionnaire for hospital survey on patient safety
culture, patient safety/drug safety situation in China, and
pharmacy experts’ experiences, there may be other po-
tential influencing factors for pharmacist’s drug safety
practice which were not contained in this study. Third,
pharmacist’s drug safety knowledge, drug safety attitude,
and detailed aspects of drug safety environment
interrelated with each other, which may affect their
relative importance in influencing pharmacist’s drug
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safety practice.
Target audience
Findings in this study may prove useful for both phar-
macists and regulators among different districts of
China. Pharmacist in different district could find the
corresponding effective way to promote her/his drug
safety practice through promoting corresponding major
influencing factors. Regulator in different district could
implement the corresponding effective intervention for
pharmacist’s drug safety practice through targeted laws,
policies, regulations, and measures, for example, pro-
moting hospital drug safety culture, supervisor’s work
team management, cooperation atmosphere of work
team, and drug safety culture of work team through tar-
geted laws, policies, regulations, and measures could
help promote pharmacist’s drug safety practice in
regions with higher per capita GDP and more abundant
medical resources, but they could only first help estab-
lish the link between pharmacist’s drug safety practice
and hospital drug safety culture/supervisor’s work team
management/cooperation atmosphere of work team/
drug safety culture of work team in regions with lower
per capita GDP and less abundant medical resources.
Conclusion
This study found that pharmacist’s drug safety practice
in regions with higher per capita GDP and more abun-
dant medical resources was still better than that in
regions with lower per capita GDP and less abundant
medical resources, and then regional inequity in phar-
macist’s drug safety practice still existed in China. Phar-
macist’s drug safety knowledge, drug safety attitude, self-
perceived pressure and fatigue, hospital management
quality, and hospital regulation were major influencing
factors for pharmacist’s drug safety practice in all dis-
tricts of China, while only in regions with higher per
capita GDP and more abundant medical resources, hos-
pital drug safety culture, supervisor’s work team man-
agement, cooperation atmosphere of work team, and
drug safety culture of work team were major influencing
factors for pharmacist’s drug safety practice.
For China’s future health delivery system reform,
inspirations on regional differences in effective ways to
promote patient safety and drug safety through promot-
ing pharmacist’s drug safety practice were found as fol-
lows: in all districts of China, promoting pharmacist’s
drug safety knowledge, drug safety attitude, self-
perceived pressure and fatigue, hospital management
quality, and hospital regulation could help promote
pharmacist’s drug safety practice, while only in regions
with higher per capita GDP and more abundant medical
resources, promoting hospital drug safety culture,supervisor’s work team management, cooperation at-
mosphere of work team, and drug safety culture of work
team could help promote pharmacist’s drug safety prac-
tice. And in regions with lower per capita GDP and less
abundant medical resources, the link between pharmacist’s
drug safety practice and hospital drug safety culture/
supervisor’s work team management/cooperation atmo-
sphere of work team/drug safety culture of work team
should also be gradually established.
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